Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,014 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Active, Not Recruiting

Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom

NCT02952508

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Central Nervous System Lymphoma, +36 more
Locations
  • Cellectar Biosciences site Los Angeles, California, United States
  • Cellectar Biosciences site Redlands, California, United States
  • Cellectar Biosciences site Washington D.C., District of Columbia, United States
  • Cellectar Biosciences site Jacksonville, Florida, United States
View all 52 locations
View Trial Details
Active, Not Recruiting

Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test

NCT04635384

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +15 more
Locations
  • University of California Irvine Brisbane, California, United States
  • City of Hope Duarte, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
View Trial Details
Active, Not Recruiting

Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL

NCT05478512

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Ematologia AOU Careggi Florence, Italy
  • Ematologia IRST D.Amadori Meldola, Italy
  • Ematologia AO di Perugia Perugia, Italy
  • Ematologia Ospedale S.M. delle Croci Ravenna, Italy
View Trial Details
Active, Not Recruiting

A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)

NCT05624554

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Highlands Oncology Group ( Site 5205) Springdale, Arkansas, United States
  • Clermont Oncology Center ( Site 5224) Clermont, Florida, United States
  • Hattiesburg Clinic Hematology/Oncology ( Site 5216) Hattiesburg, Mississippi, United States
  • Medical Oncology Associates, PS ( Site 5206) Spokane, Washington, United States
View all 97 locations
View Trial Details
Active, Not Recruiting

PICAROS - Acalabrutinib RWE on 1L CLL in Spain

NCT05999877

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Almería, Andalusia, Spain
  • Research Site Córdoba, Andalusia, Spain
  • Research Site Granada, Andalusia, Spain
  • Research Site Jaén, Andalusia, Spain
View all 47 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

NCT03336333

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Augusta University Augusta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Research Medical Center Kansas City, Missouri, United States
View all 158 locations
View Trial Details
Active, Not Recruiting

Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients

NCT05306301

Conditions
Chemotherapy, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Ematologia con Unità di Trapianto Avellino, AV, Italy
  • Ematologia Presidio Ospedaliero Tortora Pagani, SA, Italy
  • Ematologia ASST Papa Giovanni XXIII Bergamo, Italy
  • Ematologia AOU S.ORSOLA-MALPIGHI Bologna, Italy
View all 24 locations
View Trial Details

Related conditions